JPRN-jRCT1080224121已完成未知
Drug Use Surveillance for ADCETRIS Intravenous Infusion Untreated CD30-Positive Hodgkin's Lymphoma
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 113
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Untreated participants
- •2. CD30-positive participants
- •3. Participants on concomitant Brentuximab vedotin and AVD
排除标准
- •1. Participants contraindicated for Brentuximab vedotin
研究者
相似试验
招募中
不适用
A Survey of Brentuximab Vedotin in Pediatric Participants with Hodgkin LymphomaHodgkin LymphomaJPRN-jRCT2031220244Contact for Clinical Trial Information8
已完成
不适用
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion Relapsed or refractory CD30-positive peripheral T cell lymphoma or Pediatric Hodgkin LymphomaPeripheral T cell lymphoma and Pediatric Hodgkin lymphomaJPRN-jRCT1080224999Takeda Pharmaceutical Company Limited95
未知
Unknown
ADCETRIS IV Infusion - Special drug use surveillance (all-case surveillance) Relapsed or refractory CD30+ Hodgkin's lymphoma or anaplastic large cell lymphomaRelapsed or refractory CD30+ Hodgkin's lymphoma or anaplastic large cell lymphomaJPRN-jRCT1080222405TAKEDA PHARMACEUTICAL COMPANY LTD.140
已完成
不适用
Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"Untreated CD30-Positive Hodgkin's LymphomaNCT03729609Takeda113
已完成
不适用
Therapeutic Drug Monitoring of Intravenous Busulfan in Thai Children Undergoing Hematopoietic Stem Cell Transplantation: A Pilot StudyAllogeneic hematopoietic stem cell transplantation (HSCT) is widely used as a primary treatment for various malignant disorders (eg,acute myeloid leukemia) and non-malignant disorders (eg,thalassemibusulfantherapeutic drug monitoringarea under the curvetransplantationchildrenTCTR20190528003Faculty of Medicine, Mahidol University, Thailand10